Complex Discovery

JUNE 17, 2024

states over talcum powder litigation marks a pivotal moment in consumer protection and corporate accountability. This case highlights critical issues surrounding product safety, transparency, and the ethical responsibilities of corporations, especially within the pharmaceutical industry. for Mass., $6m 6m for N.H., nearly $7m for R.I.

Litigation 111

Litigation Pharmaceuticals Manufacturing Evidence 111

IP Watchdog

APRIL 29, 2024

GlaxoSmithKline filed a four-count civil action for patent infringement in the United States District Court for the District of Delaware late last week seeking damages for Pfizer and BioNTech’s infringing manufacture, use, sale and marketing of both the original “monovalent” and “bivalent” Comirnaty COVID-19 vaccines.

Manufacturing 111

Manufacturing Pharmaceuticals Technology Litigation 111

IP Watchdog

JULY 29, 2021

Earlier today, the Senate Judiciary Committee held an Executive Business Meeting in which the Committee discussed and favorably reported four bills aimed at reducing prescription drug prices for consumers and curbing perceived abuses of the patent system by brand pharmaceutical companies. He said that nearly 40% of U.S.

Pharmaceuticals 122

Pharmaceuticals Manufacturing Litigation 122

IP Watchdog

MARCH 30, 2023

Solicitor General on Wednesday filed an amicus brief with the United States Supreme Court advising it to grant Teva Pharmaceuticals’ petition for writ of certiorari relating to generic manufacturers’ liability for infringement through the use of “skinny labels” on generic drugs. The SG’s brief said that the U.S.

Pharmaceuticals 115

Pharmaceuticals Manufacturing Litigation 115

IP Watchdog

OCTOBER 20, 2022

The People’s Vaccine Alliance, a coalition of over 100 organizations, issued a statement this week alleging that the pharmaceutical industry is attempting to tighten its control of the world’s pandemic response plans.

Pharmaceuticals 81

Pharmaceuticals Manufacturing Technology Litigation 81

IP Watchdog

SEPTEMBER 16, 2024

Court of Appeals for the Third Circuit in Bristol Myers Squibb Co. Becerra et al.

Pharmaceuticals 64

Pharmaceuticals Manufacturing Litigation 64

InHouseBlog

APRIL 8, 2022

VP, Litigation & Employment Law , www.princetonlegal.com (Princeton, NJ). Senior Director, Compliance Risk Navigation , Regeneron Pharmaceuticals (Tarrytown, NY). Regulatory Litigation Attorney , Southern California Edison (Hybrid Remote). Director, IP Litigation , Inscripta, Inc. Legal Counsel , TuneIn (Remote).

Real Estate 97

Real Estate Pharmaceuticals Litigation Technology 97